Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. 

CEO
Vikram Karnani
CEOVikram Karnani
Employees
423
Employees423
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
423
Employees423

COLL Key Statistics

Market cap
1.03B
Market cap1.03B
Price-Earnings ratio
18.62
Price-Earnings ratio18.62
Dividend yield
Dividend yield
Average volume
689.73K
Average volume689.73K
High today
$33.20
High today$33.20
Low today
$32.09
Low today$32.09
Open price
$32.85
Open price$32.85
Volume
582.95K
Volume582.95K
52 Week high
$50.79
52 Week high$50.79
52 Week low
$23.23
52 Week low$23.23

Stock Snapshot

With a market cap of 1.03B, Collegium Pharmaceutical(COLL) trades at $32.31. The stock has a price-to-earnings ratio of 18.62.

As of 2026-04-03, Collegium Pharmaceutical(COLL) stock has fluctuated between $32.09 and $33.20. The current price stands at $32.31, placing the stock +0.7% above today's low and -2.7% off the high.

The Collegium Pharmaceutical(COLL)'s current trading volume is 582.95K, compared to an average daily volume of 689.73K.

In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $50.79 and a 52-week low of $23.23.

In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $50.79 and a 52-week low of $23.23.

COLL News

Nasdaq 4d
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD

Key Points 6,224 shares were sold for a transaction value of ~$228,000 on March 9, 2026. This sale represented 6.40% of Dieter David’s direct holdings prior t...

Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.